期刊文献+

卡托普利与氯沙坦治疗肾性高血压的临床分析

下载PDF
导出
摘要 目的探讨分析卡托普利与氯沙坦治疗肾性高血压的临床疗效及用药安全。方法将我院收治的肾性高血压患者84例,随机分为两组,实验组42例使用卡托普利进行治疗,对照组42例使用氯沙坦进行治疗,观察对比两组肾性高血压疾病的治疗效果。结果实验组和对照组经过治疗血压均比治疗前下降,但实验组治疗肾性高血压疾病的血压下降更为显著,p【0.05,差异有统计学意义。结论卡托普利与氯沙坦都能有效治疗肾性高血压,卡托普利的效果更加显著,价格方面也具有优势,但氯沙坦治疗肾性高血压缓慢而持久,不良反应咳嗽发生率低于卡托普利。
出处 《中国保健营养(下半月)》 2012年第7期2810-2811,共2页 China Health Care & Nutrition
  • 相关文献

参考文献3

二级参考文献11

  • 1[1]Ruilope LM,Salvetti A,Jamerson K,et aL Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study[J].J Am Soc Nephrol,2001,12(2):218-225.
  • 2[2]Maschio G,Alberti D,LocateUi F,et aL Angiotensin-converting enzyme inhibitors and kidney protection:the AIPRI triaL The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group[J].J Cardiovasc Pharmacol,1999,33(suppl 1):S16-20.
  • 3[3]Hou FF,Zhang X,Zhang GH,et al.Efficacy and safety of benazepril for advanced chronic renal insufficiency[J].N Engl J Med,2006,354 (2):131-140.
  • 4[4]Ruggenenti P,Pema A,Gherardi G,et aL Renal function and require-ment for dialysis in chronic nephropathy patients on long-term ramipril:REIN follow-up trial.Gruppo Italiano di Studi Epidemiologici in Nefrolo-gia (GISEN)[J].Lancet,1998,352(9136):1252-1256.
  • 5[5]Parring HH,Lehnert H,Brochner MJ,et aL The effect of irbesartan on the development of diabetic ncphropathy in patients with type 2 diabetes[J].N Engl J Med,2001,345(12):870-878.
  • 6[6]Giancarlo V,Nigel MW.Microalbuminuria reduction with valsartan in patients with type-2 diabetes mellitus:a blood pressure-independent effect[J].Circulation,2002,106(3):672-678.
  • 7[7]Lewis EJ,Nunsicker LG,Clarke WR,et aL Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephrcpathy due to type 2 diabetes[J].N Engl J Med,2001,345(12):851-860.
  • 8[8]Brenner BM,Cooper ME,Zecuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients with type 2diabetes and nephrop-athy[J].New Engl J Meal,2001,345(12):861-869.
  • 9[9]Julius S,Kjeldsen SE,Weber M,et aL Outcomes in hypertensive pa-tients at high cardiovascular risk treated with regimens based on valsrtan or andodipine:the VALUE randomized trial[J].Lancet,2004,363(9426):2022-2031.
  • 10[10]Wachtell K,Dahlof B,Rokkedal J,et aL Change of left ventrieular geo-metric pattern after 1 year of antihypertensive treatment:the Losartan In-tervention For Endpoint reduction in hypertension(LIFE) study[J].J Am Heart,2002,144(6):1057-1064.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部